Showing 5,901 - 5,920 results of 21,342 for search '(( significantly ((teer decrease) OR (greater decrease)) ) OR ( significant decrease decrease ))', query time: 0.57s Refine Results
  1. 5901
  2. 5902
  3. 5903
  4. 5904
  5. 5905
  6. 5906
  7. 5907
  8. 5908
  9. 5909
  10. 5910

    Image 3_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.tif by Stefanie Wagner (743707)

    Published 2025
    “…Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”
  11. 5911

    Image 1_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.tif by Stefanie Wagner (743707)

    Published 2025
    “…Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”
  12. 5912

    Image 2_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.tif by Stefanie Wagner (743707)

    Published 2025
    “…Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”
  13. 5913

    Image 4_Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies.tif by Stefanie Wagner (743707)

    Published 2025
    “…Here, GCN correction additionally uncovered significant decreases of Lactobacillus and Faecalibacterium. …”
  14. 5914

    Summary of study eligibility criteria. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
  15. 5915

    Summary of study participation and feasibility. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
  16. 5916

    Package alternatives for deli meat. by Monireh Mahmoudi (21989413)

    Published 2025
    “…<div><p>Consumer food waste remains a significant concern in the United States, where approximately 40% of food goes uneaten, leading to major economic and environmental consequences. …”
  17. 5917

    The study timeline. by Monireh Mahmoudi (21989413)

    Published 2025
    “…<div><p>Consumer food waste remains a significant concern in the United States, where approximately 40% of food goes uneaten, leading to major economic and environmental consequences. …”
  18. 5918
  19. 5919
  20. 5920